Azithromycin – Specialist Initiated Drug Checklist (SIDC). Indication: Prophylaxis of exacerbations in COPD, asthma, bronchiectasis; and treatment of
In 2024, LifeArc announced a 10 million funding call for projects repurposing existing treatments for bronchiectasis. Several registries have also been formed (eg, the European Bronchiectasis Registry and the Bronchiectasis and NTM Research Registry) to improve understanding of non-cystic fibrosis bronchiectasis.
Inhaled or nebulised antibiotics are a major topic of ongoing research interest in reducing exacerbations in bronchiectasis. There are no licenced inhaled or nebulised antibiotics currently in bronchiectasis. Areas covered: Inhaled or nebulised ciprofloxacin as a long-term treatment in bronchiectasi
View list of generic and brand names of drugs used for treatment of Bronchiectasis(Understanding Bronchiectasis ). Find more information including dose, side effects of the Bronchiectasis
by A Chang 2024 Cited by 9Emerging drugs for bronchiectasis. An update. Chang, Anne; Marsh Emerging drugs for bronchiectasis: An update. Expert Opinion on
Global Bronchiectasis Drugs Market . The bronchiectasis drugs market is forecasted to grow by USD 326.01 mn during
Some trials test whether such treatments also work in bronchiectasis. The other type of trials are those with medications specially designed for bronchiectasis
Medicines prescribed for bronchiectasis treatment. Some of the medicines or treatments usually prescribed for bronchiectasis are antibiotics, bronchodilators, expectorants, and mucus-thinning drugs. In most cases, treatment involves a combination of medication and the use of devices and exercises to help clear the airways. Infection treatment
by J Wang 2024 Cited by 2Furthermore, nanoparticle-based drug delivery systems can protect the drugs Bronchiectasis, and the Chronic Obstructive Pulmonary Disease–Bronchiectasis
Comments
4*